![](/img/cover-not-exists.png)
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study
Spyropoulos, Alex C., Lipardi, Concetta, Xu, Jianfeng, Lu, Wentao, Suh, Eunyoung, Yuan, Zhong, Levitan, Bennett, Sugarmann, Chiara, De Sanctis, Yoriko, Spiro, Theodore E., Barnathan, Elliot S., RaskobVolume:
25
Journal:
Clinical and Applied Thrombosis/Hemostasis
DOI:
10.1177/1076029619886022
Date:
January, 2019
File:
PDF, 212 KB
2019